Noile-Immune Biotech Inc.
public_traded
Noile-Immune Biotech Inc. is publicly traded on JPX under ticker 4893.T.
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.